These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 24857275)

  • 1. Prognostic significance of lactate/proton symporters MCT1, MCT4, and their chaperone CD147 expressions in urothelial carcinoma of the bladder.
    Choi JW; Kim Y; Lee JH; Kim YS
    Urology; 2014 Jul; 84(1):245.e9-15. PubMed ID: 24857275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
    Kim Y; Choi JW; Lee JH; Kim YS
    Hum Pathol; 2015 Jan; 46(1):104-12. PubMed ID: 25456395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis.
    Bovenzi CD; Hamilton J; Tassone P; Johnson J; Cognetti DM; Luginbuhl A; Keane WM; Zhan T; Tuluc M; Bar-Ad V; Martinez-Outschoorn U; Curry JM
    Biomed Res Int; 2015; 2015():242437. PubMed ID: 26779534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance.
    Afonso J; Santos LL; Miranda-Gonçalves V; Morais A; Amaro T; Longatto-Filho A; Baltazar F
    Mol Carcinog; 2015 Nov; 54(11):1451-66. PubMed ID: 25263481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer.
    Pinheiro C; Longatto-Filho A; Simões K; Jacob CE; Bresciani CJ; Zilberstein B; Cecconello I; Alves VA; Schmitt F; Baltazar F
    Eur J Cancer; 2009 Sep; 45(13):2418-24. PubMed ID: 19628385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer.
    Pértega-Gomes N; Vizcaíno JR; Miranda-Gonçalves V; Pinheiro C; Silva J; Pereira H; Monteiro P; Henrique RM; Reis RM; Lopes C; Baltazar F
    BMC Cancer; 2011 Jul; 11():312. PubMed ID: 21787388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma.
    Pinheiro C; Albergaria A; Paredes J; Sousa B; Dufloth R; Vieira D; Schmitt F; Baltazar F
    Histopathology; 2010 Jun; 56(7):860-7. PubMed ID: 20636790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression levels of transcription factors c-Fos and c-Jun and transmembrane protein HAb18G/CD147 in urothelial carcinoma of the bladder.
    Huhe M; Liu S; Zhang Y; Zhang Z; Chen Z
    Mol Med Rep; 2017 May; 15(5):2991-3000. PubMed ID: 28358415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD147 and monocarboxylate transporters MCT1, MCT2 and MCT4 in porcine small intestine and colon.
    Sepponen K; Ruusunen M; Pakkanen JA; Pösö AR
    Vet J; 2007 Jul; 174(1):122-8. PubMed ID: 16901736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models.
    Schneiderhan W; Scheler M; Holzmann KH; Marx M; Gschwend JE; Bucholz M; Gress TM; Seufferlein T; Adler G; Oswald F
    Gut; 2009 Oct; 58(10):1391-8. PubMed ID: 19505879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocarboxylate transporters MCT1 and MCT4 are independent prognostic biomarkers for the survival of patients with clear cell renal cell carcinoma and those receiving therapy targeting angiogenesis.
    Cao YW; Liu Y; Dong Z; Guo L; Kang EH; Wang YH; Zhang W; Niu HT
    Urol Oncol; 2018 Jun; 36(6):311.e15-311.e25. PubMed ID: 29657088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression.
    Chen H; Wang L; Beretov J; Hao J; Xiao W; Li Y
    Clin Exp Metastasis; 2010 Dec; 27(8):557-69. PubMed ID: 20658178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression.
    Pinheiro C; Sousa B; Albergaria A; Paredes J; Dufloth R; Vieira D; Schmitt F; Baltazar F
    Histol Histopathol; 2011 Oct; 26(10):1279-86. PubMed ID: 21870331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexpression of MCT1 and MCT4 in ALK-positive Anaplastic Large Cell Lymphoma: Diagnostic and Therapeutic Implications.
    Choi JW; Lee Y; Kim H; Cho HY; Min SK; Kim YS
    Am J Surg Pathol; 2022 Feb; 46(2):241-248. PubMed ID: 34619707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of CD147 expression by RNA interference inhibits HT29 cell proliferation, invasion and tumorigenicity in vitro and in vivo.
    Li R; Pan Y; He B; Xu Y; Gao T; Song G; Sun H; Deng Q; Wang S
    Int J Oncol; 2013 Dec; 43(6):1885-94. PubMed ID: 24064772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells.
    Izumi H; Takahashi M; Uramoto H; Nakayama Y; Oyama T; Wang KY; Sasaguri Y; Nishizawa S; Kohno K
    Cancer Sci; 2011 May; 102(5):1007-13. PubMed ID: 21306479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD147 overexpression allows an accurate discrimination of bladder cancer patients' prognosis.
    Afonso J; Longatto-Filho A; Baltazar F; Sousa N; Costa FE; Morais A; Amaro T; Lopes C; Santos LL
    Eur J Surg Oncol; 2011 Sep; 37(9):811-7. PubMed ID: 21733655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD147 expression in advanced cutaneous squamous cell carcinoma.
    Sweeny L; Dean NR; Frederick JW; Magnuson JS; Carroll WR; Desmond RA; Rosenthal EL
    J Cutan Pathol; 2012 Jun; 39(6):603-9. PubMed ID: 22575025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral lactate metabolism in Barrett's esophagus and adenocarcinoma.
    Huhta H; Helminen O; Palomäki S; Kauppila JH; Saarnio J; Lehenkari PP; Karttunen TJ
    Oncotarget; 2017 Apr; 8(14):22894-22902. PubMed ID: 28206968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD147 immunohistochemistry discriminates between reactive mesothelial cells and malignant mesothelioma.
    Pinheiro C; Longatto-Filho A; Soares TR; Pereira H; Bedrossian C; Michael C; Schmitt FC; Baltazar F
    Diagn Cytopathol; 2012 Jun; 40(6):478-83. PubMed ID: 22619123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.